International Paper Reports First Quarter 2023 Results

CANPACK Group announced that CANPACK S.A. plans to merge with Giorgi International Holdings S.A. R.L. in Luxemburg, which is currently a direct shareholder of CANPACK S.A. The merger is planned to be executed until the end of 2024 through absorption of Giorgi International Holdings S.A. R.L. by CANPACK S.A. The purpose of the merger is simplification of the internal corporate and shareholding structure – as a consequence of the merger, CANPACK Group Inc. with a seat in the United States of America, will become a direct shareholder of CANPACK S.A.

UPM Raflatac will launch a brand new product range for medical device and healthcare industry. New RPMD is a multi-faceted adhesive that is ideal for labeling medical devices. Selection of different face materials with new RPMD adhesive are specially designed for different medical device sub-segments such as sterilization wraps and bags, infusion bags and bottles, drug-device combinations like pens, auto-injectors and inhalers and blood donation labeling. RPMD adhesive combines excellent adhesion with a tight mandrel hold on glass and plastic and is sterilization resistant and migration safe. "In April 2017 the EU Commission formally adopted two new regulations on medical devices and in vitro diagnostic medical devices. One of the main regulatory updates is the implementation of a Unique Device Identification system (UDI) that provides a globally harmonized and consistent approach for the marking and identification of medical devices", comments Markku Pietarinen, Manager, Business Segments & Pharma, Specials EMEIA. "A UDI is a code printed on a label affixed to a device or its packaging, or even directly on the device itself, in both plain text and machine-readable format. All medical devices available in the EU must comply with the new regulations by April 2020, with the deadline for in vitro diagnostic devices falling two years later, in 2022." Click Read More below for additional information.

Second Quarter 2021 Summary *Reported sales grew 16% driven by strong core sales growth and positive currency effects *Core sales (excluding currency effects) increased 10% mainly on double digit core growth in Beauty + Home and Food + Beverage, driven by increased demand for our innovative dispensing solutions along with price adjustments related to rising input costs *Reported earnings per share totaled $0.81 (an increase of 29% compared to the prior year) *Reported net income totaled $55 million for the second quarter (an increase of 32% compared to the prior year) and $139 million year-to-date (an increase of 43% compared to the prior year) *Cash flow from operations was $176 million in the first half of 2021 (a decrease of 23% compared to the prior year)